<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Clin Nephrol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Clin. Nephrol</journal-id>
      <journal-id journal-id-type="publisher-id">Dustri</journal-id>
      <journal-title-group>
        <journal-title>Clinical Nephrology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0301-0430</issn>
      <publisher>
        <publisher-name>Dustri-Verlag Dr. Karl Feistle</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23006339</article-id>
      <article-id pub-id-type="pmc">4504137</article-id>
      <article-id pub-id-type="doi">10.5414/CN107420</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group>
          <subject>Nephrology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Minimal change disease in graft versus host disease: a podocyte response to the graft? </article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Huskey</surname>
            <given-names>Janna</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rivard</surname>
            <given-names>Chris</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Myint</surname>
            <given-names>Han</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lucia</surname>
            <given-names>Scott</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smith</surname>
            <given-names>Maxwell</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shimada</surname>
            <given-names>Michiko</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ishimoto</surname>
            <given-names>Takuji</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Araya</surname>
            <given-names>Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garin</surname>
            <given-names>Eduardo H.</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Johnson</surname>
            <given-names>Richard J.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Division of Renal Disease and Hypertension,</aff>
      <aff id="A2"><label>2</label>Division of Hematology and Oncology, and</aff>
      <aff id="A3"><label>3</label>Department of Pathology, University of Colorado, Denver, CO,</aff>
      <aff id="A4"><label>4</label>Division of Pathology Mayo Clinic Phoenix, Phoenix, AZ, and</aff>
      <aff id="A5"><label>5</label>Division of Pediatric Nephrology, University of Florida, Gainesville, FL, USA</aff>
      <author-notes>
        <corresp id="COR1">Correspondence to Dr. Janna Huskey Division of Nephrology, Mayo Clinic Arizona, Phoenix, AZ, USA <email>huskey.janna@ mayo.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>9</month>
        <year>2013</year>
      </pub-date>
      <volume>80</volume>
      <issue>6</issue>
      <fpage>469</fpage>
      <lpage>473</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>8</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>26</day>
          <month>4</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Dustri-Verlag Dr. K. Feistle</copyright-statement>
        <copyright-year>2013 </copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Nephrotic syndrome is a rare complication of hematopoietic cell transplantation. It has been suggested that nephrotic syndrome may represent a limited form of graft-versus-host disease although the pathological link between these two entities remains unclear. In this paper, we report a case of a 61-year-old female who underwent nonmyeloablative allogenic stem cell transplantation for T-cell prolymphocytic leukemia and subsequently developed biopsy proven minimal change disease shortly after cessation of her immunosuppression therapy. Urinary CD80 was markedly elevated during active disease and disappeared following corticosteroid-induced remission. We hypothesize that alloreactive donor T cells target the kidney and induce podocyte expression of CD80 that results in proteinuria from limited &#x2018;graft versus host&#x2019; disease. </p>
      </abstract>
      <kwd-group>
        <kwd>graft versus host disease</kwd>
        <kwd>minimal change disease</kwd>
        <kwd>urinary CD80</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction </title>
      <p>Hematopoietic cell transplantation (HCT) is an established treatment for various hematologic diseases. Acute kidney injury (AKI) complicates 22&#xA0;&#x2013;&#xA0;76% of patients with HCT depending on the type of transplant received [<xref rid="b1" ref-type="bibr">1</xref>]. Radiation nephropathy, calcineurin inhibitor toxicity, transplant-associated thrombotic microangiopathy, and chronic graft-vs.-host disease (GVHD) contribute to chronic kidney disease and develops in ~&#xA0;17% of patients [<xref rid="b2" ref-type="bibr">2</xref>, <xref rid="b3" ref-type="bibr">3</xref>]. The development of nephrotic syndrome after HCT is unusual [<xref rid="b4" ref-type="bibr">4</xref>, <xref rid="b5" ref-type="bibr">5</xref>, <xref rid="b6" ref-type="bibr">6</xref>, <xref rid="b7" ref-type="bibr">7</xref>, <xref rid="b8" ref-type="bibr">8</xref>, <xref rid="b9" ref-type="bibr">9</xref>]. Whilst a variety of glomerular diseases have been noted, the most commonly observed nephrotic syndrome after HCT is membranous nephropathy followed by minimal change disease (MCD) [<xref rid="b6" ref-type="bibr">6</xref>, <xref rid="b7" ref-type="bibr">7</xref>, <xref rid="b8" ref-type="bibr">8</xref>, <xref rid="b9" ref-type="bibr">9</xref>, <xref rid="b10" ref-type="bibr">10</xref>, <xref rid="b11" ref-type="bibr">11</xref>, <xref rid="b12" ref-type="bibr">12</xref>]. It has been suggested that a link between chronic GVHD and glomerular disease exists, however the pathogenesis remains unclear [<xref rid="b7" ref-type="bibr">7</xref>]. </p>
      <p>T cells play a crucial role in the pathogenesis of both GVHD and MCD [<xref rid="b13" ref-type="bibr">13</xref>, <xref rid="b14" ref-type="bibr">14</xref>, <xref rid="b15" ref-type="bibr">15</xref>, <xref rid="b16" ref-type="bibr">16</xref>]. In chronic GVHD, alloreactivity, and possible autoreactivity, of donor T cells leads to cytokine stimulation, B cell activation, autoantibody production, and organ damage [<xref rid="b17" ref-type="bibr">17</xref>]. MCD has been commonly thought of as a T cell disorder and has recently been proposed to be a &#x201C;two hit&#x201D; podocyte immune disorder [<xref rid="b18" ref-type="bibr">18</xref>]. First, an immunologic stimulus results in podocyte expression of CD80, a transmembrane protein expressed on antigen presenting cells (APCs) involved in costimulation and T-cell activation [<xref rid="b19" ref-type="bibr">19</xref>]. This leads to rearrangement of the actin cytoskeleton, alterations in the slit diaphragm, and proteinuria [<xref rid="b19" ref-type="bibr">19</xref>]. The &#x201C;second hit&#x201D; results from dysfunctional T regulatory cells (Tregs) which are unable to inactivate the immunologic stimulus that triggers the increased podocyte CD80 expression leading to persistent nephrotic syndrome [<xref rid="b18" ref-type="bibr">18</xref>]. We present a case of biopsy proven GVHD associated MCD, as a sole manifestation of chronic GVHD, in which we hypothesize that the alloreactive donor T cells serve as the immunologic stimulus that leads to podocyte expression of CD80 and nephrotic syndrome. </p>
    </sec>
    <sec id="s2">
      <title>Case</title>
      <p>A 61-year-old female with T-cell prolymphocytic leukemia underwent an allogenic stem cell transplant from her sister who served as a 10 out of 10 HLA-matched sibling donor in August 2008. In 2005, she presented with leukocytosis and bone marrow biopsy revealed T-cell prolymphocytic leukemia for which she received alemtuzumab, a humanized anti-CD52 antibody, and subsequently went into remission. Repeat bone marrow biopsy in 2008 revealed disease recurrence at which time a reduced intensity conditioned allogenic stem cell transplant was performed (conditioned with fludarebine and melphalan) without any major complications. Her (GVHD) prophylaxis was tacrolimus and methotrexate, as per our institutional protocol. Day 100 after transplant, her tacrolimus dose was lowered and within a few weeks, she developed a rash that was consistent with a clinical diagnosis of chronic GVHD. Prednisone (1 mg/kg) was initiated and tacrolimus was increased. As her rash improved, her immunosuppression was gradually tapered over 9 months. </p>
      <p>Three weeks after stopping all immunosuppression, she developed nausea, fatigue, and edema. She was noted to have new onset nephrotic syndrome manifested by anasarca, hypoalbuminemia (1.8 mg/dl), hyperlipidemia (total cholesterol 307 mg/dl with LDL 185 mg/dl, triglycerides 396 mg/dl), proteinuria (19.9 g/day) and an elevated serum Cr of 2.4 mg/dl (baseline 0.9&#xA0;&#x2013;&#xA0;1.1 since May 2008). Extensive serologic workup was negative. Renal biopsy revealed interstitial inflammation, tubulitis, tubular atrophy and normal glomeruli by light microscopy with diffuse foot process effacement on electron microscopy (<xref ref-type="fig" rid="Figure1">Figure 1</xref>). JC virus, Epstein-Bar virus, and cytomegalovirus immunohistochemical stains were negative. Urine eosinophils, serum and urine BK virus, serum enterovirus, serum HHV-6, and serum HHV-8 were negative. Short tandem repeat chimerism studies showed that ~ 32% of the DNA material in the biopsy specimen originated from donor cells [<xref rid="b5" ref-type="bibr">5</xref>]. Immunohistochemical stains showed a predominantly CD3 positive T-cell infiltrate with increased CD8+ T cells. Repeat bone marrow biopsy was negative for disease recurrence and she had full donor chimerism of all fractions tested including CD3, CD33, and CD56 on her bone marrow. The presence of donor T cells in her kidney, lack of nephrotoxic medications such as non-steroid anti-inflammatory drugs, and a bone marrow biopsy indicating full donor chimerism without signs of disease recurrence lead to a diagnosis of chronic GVHD in the kidney manifested as MCD. </p>
      <p>The patient received prednisone 2 mg/kg/d, furosemide, and statin therapy and was discharged from the hospital with a Cr of 2.9 mg/dl (peaked at 3.2 mg/dl). Within 8 weeks, her proteinuria had improved to 1.3 g/d and her Cr decreased to 0.9 &#x2013; 1.1 mg/dl. The prednisone was tapered over 4 months and she went into complete renal remission with&#xA0;&lt;&#xA0;500 mg protein in a 24-h urine collection. Nevertheless, her rash returned and mycophenolate mofetil was added to her regimen of prednisone 15 mg/d for GVHD. Over the next several months, her proteinuria improved and the mycophenolate mofetil was discontinued, and in July 2010 her prednisone was decreased to 5 mg every other day. In September 2010, her nephrotic syndrome returned with proteinuria (9.5 g/d), anasarca (11.3 kg weight gain), hyperlipidemia (total cholesterol 332 mg/dl, LDL 229 mg/dl, triglycerides 270 mg/dl), and a Cr of 1.9 mg/dl. Her prednisone was increased to 1 mg/kg and furosemide and statin therapy were restarted. Repeat chimerism of the peripheral blood confirmed full donor chimerism on all 3 fractions tested. By December 2010, her proteinuria fell to 500 mg/d and her renal function returned to baseline. She was treated with a slow prednisone taper and continues to remain in remission with undetectable proteinuria on prednisone 10 mg daily. </p>
    </sec>
    <sec id="s3">
      <title>Urinary detection of CD80 </title>
      <p>We have reported that children with idiopathic MCD express CD80 in their podocytes in association with high levels of the membrane-bound (53 Kd) CD80 protein in their urine during relapse [<xref rid="b20" ref-type="bibr">20</xref>, <xref rid="b21" ref-type="bibr">21</xref>]. To determine if a similar pattern was occurring in this patient, and following consent of the patient and approval by the University Human Subjects Committee, urine was collected both during relapse and following remission and Western blotting for CD80 was performed according to standard procedures [<xref rid="b21" ref-type="bibr">21</xref>]. As shown in <xref ref-type="fig" rid="Figure2">Figure 2</xref>, a marked increased urinary excretion of membrane-bound CD80 (53 Kd) was observed during relapse. Excretion was dramatically lower but still slightly detectable when her proteinuria improved to ~ 600 mg/day and was absent in a healthy control. Glomerular staining for CD80 was not attempted due to lack of frozen tissue that is required for immunostaining with the anti-CD80 antibody. </p>
    </sec>
    <sec id="s4">
      <title>Discussion </title>
      <p>MCD is classically considered a T-cell disorder [<xref rid="b13" ref-type="bibr">13</xref>]. A breakthrough in our understanding of this condition was provided by Reiser et al. [<xref rid="b19" ref-type="bibr">19</xref>] who discovered that CD80, a receptor normally expressed on dendritic cells, can be induced in podocytes. The injection of lipopolysaccharide (LPS) in mice resulted in CD80 expression in the podocytes with foot process effacement and proteinuria and this was not observed when LPS was injected into CD80 knockout mice [<xref rid="b19" ref-type="bibr">19</xref>]. As the histologic findings were similar to MCD, Reiser and Mundel [<xref rid="b22" ref-type="bibr">22</xref>] suggested that this might underlie the pathogenesis of this condition. Our group subsequently documented that urinary CD80 excretion is high in corticosteroid responsive MCD and appears to be relatively specific to this disease entity [<xref rid="b20" ref-type="bibr">20</xref>, <xref rid="b21" ref-type="bibr">21</xref>]. Urinary CD80 values are significantly higher in patients with relapsing MCD when compared with patients with MCD in remission, other glomerular diseases such as focal segmental glomerulosclerosis (FSGS) or membranous nephropathy, and healthy controls [<xref rid="b20" ref-type="bibr">20</xref>, <xref rid="b21" ref-type="bibr">21</xref>]. We were able to identify CD80 in the podocytes of a limited number of renal biopsies of relapsing MCD, and to show that the CD80 present in the urine was the membrane-bound (53Kd MW) form and not circulating soluble CD80 (23 Kd MW) [<xref rid="b21" ref-type="bibr">21</xref>]. Here we report a case of corticosteroid-sensitive MCD associated with GVHD that is also associated with increased urinary CD80 expression. While we were not able to determine if CD80 was expressed in the glomerulus, the observation that the urinary CD80 in this patient was membrane bound (53 Kd MW) and not the circulating form (23 Kd MW) strongly suggests that the pathogenesis of the proteinuria in this case is similar to MCD and is a form of CD80 podocytopathy. </p>
      <p>In mice, the induction of proteinuria by LPS results in only transient CD80 expression and transient proteinuria [<xref rid="b19" ref-type="bibr">19</xref>]. Since CD80 can be induced in podocytes by various Toll-like receptor ligands and cytokines, we have hypothesized that this might explain the transient proteinuria that is occasionally observed in febrile patients [<xref rid="b23" ref-type="bibr">23</xref>]. However, persistent CD80 expression might require the continuous exposure of a cytokine because of impaired Tregs [<xref rid="b24" ref-type="bibr">24</xref>] or the inability of the host podocyte to censor the CD80 response [<xref rid="b23" ref-type="bibr">23</xref>]. </p>
      <p>In this case, GVHD provides a mechanism for continuous immune stimulation by the grafted cells to the host. T cells from the graft have been identified in the interstitium of subjects with MCD following allogeneic stem cell transplantation [<xref rid="b5" ref-type="bibr">5</xref>]. Furthermore, a reduced Treg population has been associated with chronic GVHD [<xref rid="b25" ref-type="bibr">25</xref>]. Finally, a recent study found a reduction in Tregs in the kidney biopsies of subjects with nephrotic syndrome (of various causes) following allogeneic stem cell transplantation [<xref rid="b26" ref-type="bibr">26</xref>]. This reduction in Tregs might facilitate the clonal expansion of host reactive T cells (memory function primed to antigens on the podocyte) that could be responsible for the disease. Since the podocyte can function as a dendritic cell and can express CD80 in the setting of an immunologic stimulus, such as T cell directed response to antigens on the podocyte, this could provide a mechanism for explaining the pathogenesis of proteinuria in this condition. It also remains possible that either methotrexate or tacrolimus may have a role in the proteinuria, although neither agents are associated with the development of MCD in the nontransplant setting [<xref rid="b27" ref-type="bibr">27</xref>, <xref rid="b28" ref-type="bibr">28</xref>]. Further studies are needed to better identify the cellular mechanisms driving the CD80 response in this disease. </p>
    </sec>
    <sec id="s5">
      <title>Funding </title>
      <p>Supported by NIH grant DK-80764. </p>
      <fig id="Figure1" orientation="portrait" position="float">
        <label>Figure 1.</label>
        <caption>
          <title>Light and EM. a: Normal glomerulus showing open capillary loops, thin delicate basement membranes, and no significant hypercellularity. No segmental scars were identified (400&#xD7;, PAS stain). b:&#xA0;Interstitial inflammation and tubular damage (400&#xD7;, H&amp;E stain). c: CD3 predominant T-cell interstitial inflammatory cell infiltrate with areas of tubulitis (arrow) (400&#xD7;, CD3 immunohistochemical stain). d: Severe foot process effacement (podocyte fusion) (arrow) (Electron Microscopy).</title>
        </caption>
        <graphic xlink:href="clinnephrol-80-469-01"/>
      </fig>
      <fig id="Figure2" orientation="portrait" position="float">
        <label>Figure 2.</label>
        <caption>
          <title>Western blot of urinary CD80: Urine samples were warmed to room temperature, vortexed, and centrifuged at 8,000 g for 5 min. Total urine protein was determined by the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA). 30 &#xB5;g total protein was loaded per lane in a 4&#xA0;&#x2013;&#xA0;20% precast Criterion polyacrylamide gel (Bio-Rad, #345-0033, Hercules, CA, USA). Proteins were transferred to an Immobilon transfer membrane (Millipore, Billerica, MA, USA), blocked for 1 hour in 5% milk and incubated overnight at 4&#xA0;&#xB0;C with anti-CD80 antibody (R&amp;D Systems, #AF-140, Minneapolis, MN, USA). The membrane was washed in Tween-Tris Buffered Saline (TTBS) and revealed using an antimouse horse radish peroxidase (HRP) linked secondary antibody (Cell Signalin, #7076S, Danvers, MA, USA) and Immun-Star reagent (Bio-Rad). The membrane was exposed to film and images evaluated for densitometry using 1D Image Software (Kodak Digital Science, Rochester, NY, USA). Patient urine samples collected during MCD relapse (8.9 g, 10.4 g of proteinuria) and during partial remission (0.6 g proteinuria) were compared to a healthy control urine sample. All samples were frozen following collection at &#x2013;20&#xA0;&#xB0;C until analyzed.</title>
        </caption>
        <graphic xlink:href="clinnephrol-80-469-02"/>
      </fig>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <label>1</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Parikh</surname><given-names>CR</given-names></name>
<name><surname>Coca</surname><given-names>SG</given-names></name>
<article-title>Acute renal failure in hematopoietic cell transplantation.</article-title>
<source>Kidney Int</source>.
<year>2006</year>;
<volume>69</volume>:
<fpage>430</fpage>&#x2013;<lpage>435</lpage>.
<pub-id pub-id-type="pmid">16395267</pub-id></mixed-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Ellis</surname><given-names>MJ</given-names></name>
<name><surname>Parikh</surname><given-names>CR</given-names></name>
<name><surname>Inrig</surname><given-names>JK</given-names></name>
<name><surname>Kanbay</surname><given-names>M</given-names></name>
<name><surname>Patel</surname><given-names>UD</given-names></name>
<article-title>Chronic kidney disease after hematopoietic cell transplantation: a systematic review.</article-title>
<source>Am J Transplant</source>.
<year>2008</year>;
<volume>8</volume>:
<fpage>2378</fpage>&#x2013;<lpage>2390</lpage>.
<pub-id pub-id-type="pmid">18925905</pub-id></mixed-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Cohen</surname><given-names>EP</given-names></name>
<article-title>Renal failure after bone-marrow transplantation.</article-title>
<source>Lancet</source>.
<year>2001</year>;
<volume>357</volume>:
<fpage>6</fpage>&#x2013;<lpage>7</lpage>.
<pub-id pub-id-type="pmid">11197374</pub-id></mixed-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Ferrara</surname><given-names>JL</given-names></name>
<name><surname>Levine</surname><given-names>JE</given-names></name>
<name><surname>Reddy</surname><given-names>P</given-names></name>
<name><surname>Holler</surname><given-names>E</given-names></name>
<article-title>Graft-versus-host disease.</article-title>
<source>Lancet</source>.
<year>2009</year>;
<volume>373</volume>:
<fpage>1550</fpage>&#x2013;<lpage>1561</lpage>.
<pub-id pub-id-type="pmid">19282026</pub-id></mixed-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Romagnani</surname><given-names>P</given-names></name>
<name><surname>Lazzeri</surname><given-names>E</given-names></name>
<name><surname>Mazzinghi</surname><given-names>B</given-names></name>
<name><surname>Lasagni</surname><given-names>L</given-names></name>
<name><surname>Guidi</surname><given-names>S</given-names></name>
<name><surname>Bosi</surname><given-names>A</given-names></name>
<name><surname>Cirami</surname><given-names>C</given-names></name>
<name><surname>Salvadori</surname><given-names>M</given-names></name>
<article-title>Nephrotic syndrome and renal failure after allogeneic stem cell transplantation: novel molecular diagnostic tools for a challenging differential diagnosis.</article-title>
<source>Am J Kidney Dis</source>.
<year>2005</year>;
<volume>46</volume>:
<fpage>550</fpage>&#x2013;<lpage>556</lpage>.
<pub-id pub-id-type="pmid">16129218</pub-id></mixed-citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Rao</surname><given-names>PS</given-names></name>
<article-title>Nephrotic syndrome in patients with peripheral blood stem cell transplant.</article-title>
<source>Am J Kidney Dis</source>.
<year>2005</year>;
<volume>45</volume>:
<fpage>780</fpage>&#x2013;<lpage>785</lpage>.
<pub-id pub-id-type="pmid">15806483</pub-id></mixed-citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Brukamp</surname><given-names>K</given-names></name>
<name><surname>Doyle</surname><given-names>AM</given-names></name>
<name><surname>Bloom</surname><given-names>RD</given-names></name>
<name><surname>Bunin</surname><given-names>N</given-names></name>
<name><surname>Tomaszewski</surname><given-names>JE</given-names></name>
<name><surname>Cizman</surname><given-names>B</given-names></name>
<article-title>Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?</article-title>
<source>Clin J Am Soc Nephrol</source>.
<year>2006</year>;
<volume>1</volume>:
<fpage>685</fpage>&#x2013;<lpage>694</lpage>.
<pub-id pub-id-type="pmid">17699273</pub-id></mixed-citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Akar</surname><given-names>H</given-names></name>
<name><surname>Keven</surname><given-names>K</given-names></name>
<name><surname>Celebi</surname><given-names>H</given-names></name>
<name><surname>Orhan</surname><given-names>D</given-names></name>
<name><surname>Nergizo&#x11F;lu</surname><given-names>G</given-names></name>
<name><surname>Erbay</surname><given-names>B</given-names></name>
<name><surname>Tulunay</surname><given-names>O</given-names></name>
<name><surname>Ozcan</surname><given-names>M</given-names></name>
<name><surname>Ert&#xFC;rk</surname><given-names>S</given-names></name>
<article-title>Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation.</article-title>
<source>J Nephrol</source>.
<year>2002</year>;
<volume>15</volume>:
<fpage>79</fpage>&#x2013;<lpage>82</lpage>.
<pub-id pub-id-type="pmid">11936432</pub-id></mixed-citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Kemper</surname><given-names>MJ</given-names></name>
<name><surname>G&#xFC;ng&#xF6;r</surname><given-names>T</given-names></name>
<name><surname>Halter</surname><given-names>J</given-names></name>
<name><surname>Schanz</surname><given-names>U</given-names></name>
<name><surname>Neuhaus</surname><given-names>TJ</given-names></name>
<article-title>Favorable long-term outcome of nephrotic syndrome after allogeneic hematopoietic stem cell transplantation.</article-title>
<source>Clin Nephrol</source>.
<year>2007</year>;
<volume>67</volume>:
<fpage>5</fpage>&#x2013;<lpage>11</lpage>.
<pub-id pub-id-type="pmid">17269593</pub-id></mixed-citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Fofi</surname><given-names>C</given-names></name>
<name><surname>Barberi</surname><given-names>S</given-names></name>
<name><surname>Stoppacciaro</surname><given-names>A</given-names></name>
<name><surname>Punzo</surname><given-names>G</given-names></name>
<name><surname>Men&#xE8;</surname><given-names>P</given-names></name>
<article-title>Focal segmental glomerulosclerosis as a complication of graft-versus-host disease.</article-title>
<source>Nat Rev Nephrol</source>.
<year>2009</year>;
<volume>5</volume>:
<fpage>236</fpage>&#x2013;<lpage>240</lpage>.
<pub-id pub-id-type="pmid">19322189</pub-id></mixed-citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Kaminska</surname><given-names>D</given-names></name>
<name><surname>Bernat</surname><given-names>B</given-names></name>
<name><surname>Vakulenko</surname><given-names>O</given-names></name>
<name><surname>Kuzniar</surname><given-names>J</given-names></name>
<name><surname>Tyran</surname><given-names>B</given-names></name>
<name><surname>Suchnicki</surname><given-names>K</given-names></name>
<name><surname>Lange</surname><given-names>A</given-names></name>
<name><surname>Mazanowska</surname><given-names>O</given-names></name>
<name><surname>Halon</surname><given-names>A</given-names></name>
<name><surname>Klinger</surname><given-names>M</given-names></name>
<article-title>Glomerular lesion and increased cytokine gene expression in renal tissue in patients with decompensated nephrotic syndrome due to chronic GvHD.</article-title>
<source>Ren Fail</source>.
<year>2010</year>;
<volume>32</volume>:
<fpage>510</fpage>&#x2013;<lpage>514</lpage>.
<pub-id pub-id-type="pmid">20446793</pub-id></mixed-citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Suehiro</surname><given-names>T</given-names></name>
<name><surname>Masutani</surname><given-names>K</given-names></name>
<name><surname>Yokoyama</surname><given-names>M</given-names></name>
<name><surname>Tokumoto</surname><given-names>M</given-names></name>
<name><surname>Tsuruya</surname><given-names>K</given-names></name>
<name><surname>Fukuda</surname><given-names>K</given-names></name>
<name><surname>Kanai</surname><given-names>H</given-names></name>
<name><surname>Katafuchi</surname><given-names>R</given-names></name>
<name><surname>Nagatoshi</surname><given-names>Y</given-names></name>
<name><surname>Hirakata</surname><given-names>H</given-names></name>
<article-title>Diffuse proliferative glomerulonephritis after bone marrow transplantation.</article-title>
<source>Clin Nephrol</source>.
<year>2002</year>;
<volume>58</volume>:
<fpage>231</fpage>&#x2013;<lpage>237</lpage>.
<pub-id pub-id-type="pmid">12356194</pub-id></mixed-citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Shalhoub</surname><given-names>RJ</given-names></name>
<article-title>Pathogenesis of lipoid nephrosis: a disorder of T-cell function.</article-title>
<source>Lancet</source>.
<year>1974</year>;
<volume>304</volume>:
<fpage>556</fpage>&#x2013;<lpage>560</lpage>.
<pub-id pub-id-type="pmid">4140273</pub-id></mixed-citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Mathieson</surname><given-names>PW</given-names></name>
<article-title>Immune dysregulation in minimal change nephropathy.</article-title>
<source>Nephrol Dial Transplant</source>.
<year>2003</year>;
<volume>18</volume>:
<fpage>vi26</fpage>&#x2013;<lpage>vi29</lpage>.
<pub-id pub-id-type="pmid">12953038</pub-id></mixed-citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Grimbert</surname><given-names>P</given-names></name>
<name><surname>Audard</surname><given-names>V</given-names></name>
<name><surname>Remy</surname><given-names>P</given-names></name>
<name><surname>Lang</surname><given-names>P</given-names></name>
<name><surname>Sahali</surname><given-names>D</given-names></name>
<article-title>Recent approaches to the pathogenesis of minimal-change nephrotic syndrome.</article-title>
<source>Nephrol Dial Transplant</source>.
<year>2003</year>;
<volume>18</volume>:
<fpage>245</fpage>&#x2013;<lpage>248</lpage>.
<pub-id pub-id-type="pmid">12543875</pub-id></mixed-citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Soci&#xE9;</surname><given-names>G</given-names></name>
<name><surname>Blazar</surname><given-names>BR</given-names></name>
<article-title>Acute graft-versus-host disease: from the bench to the bedside.</article-title>
<source>Blood</source>.
<year>2009</year>;
<volume>114</volume>:
<fpage>4327</fpage>&#x2013;<lpage>4336</lpage>.
<pub-id pub-id-type="pmid">19713461</pub-id></mixed-citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>P&#xE9;rez-Sim&#xF3;n</surname><given-names>JA</given-names></name>
<name><surname>S&#xE1;nchez-Abarca</surname><given-names>I</given-names></name>
<name><surname>D&#xED;ez-Campelo</surname><given-names>M</given-names></name>
<name><surname>Caballero</surname><given-names>D</given-names></name>
<name><surname>San Miguel</surname><given-names>J</given-names></name>
<article-title>Chronic graft-versus-host disease: Pathogenesis and clinical management.</article-title>
<source>Drugs</source>.
<year>2006</year>;
<volume>66</volume>:
<fpage>1041</fpage>&#x2013;<lpage>1057</lpage>.
<pub-id pub-id-type="pmid">16789791</pub-id></mixed-citation>
      </ref>
      <ref id="b18">
        <label>18</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Shimada</surname><given-names>M</given-names></name>
<name><surname>Araya</surname><given-names>C</given-names></name>
<name><surname>Rivard</surname><given-names>C</given-names></name>
<name><surname>Ishimoto</surname><given-names>T</given-names></name>
<name><surname>Johnson</surname><given-names>RJ</given-names></name>
<name><surname>Garin</surname><given-names>EH</given-names></name>
<article-title>Minimal change disease: a &#x201C;two-hit&#x201D; podocyte immune disorder?</article-title>
<source>Pediatr Nephrol</source>.
<year>2011</year>;
<volume>26</volume>:
<fpage>645</fpage>&#x2013;<lpage>649</lpage>.
<pub-id pub-id-type="pmid">21052729</pub-id></mixed-citation>
      </ref>
      <ref id="b19">
        <label>19</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Reiser</surname><given-names>J</given-names></name>
<name><surname>von Gersdorff</surname><given-names>G</given-names></name>
<name><surname>Loos</surname><given-names>M</given-names></name>
<name><surname>Oh</surname><given-names>J</given-names></name>
<name><surname>Asanuma</surname><given-names>K</given-names></name>
<name><surname>Giardino</surname><given-names>L</given-names></name>
<name><surname>Rastaldi</surname><given-names>MP</given-names></name>
<name><surname>Calvaresi</surname><given-names>N</given-names></name>
<name><surname>Watanabe</surname><given-names>H</given-names></name>
<name><surname>Schwarz</surname><given-names>K</given-names></name>
<name><surname>Faul</surname><given-names>C</given-names></name>
<name><surname>Kretzler</surname><given-names>M</given-names></name>
<name><surname>Davidson</surname><given-names>A</given-names></name>
<name><surname>Sugimoto</surname><given-names>H</given-names></name>
<name><surname>Kalluri</surname><given-names>R</given-names></name>
<name><surname>Sharpe</surname><given-names>AH</given-names></name>
<name><surname>Kreidberg</surname><given-names>JA</given-names></name>
<name><surname>Mundel</surname><given-names>P</given-names></name>
<article-title>Induction of B7-1 in podocytes is associated with nephrotic syndrome.</article-title>
<source>J Clin Invest</source>.
<year>2004</year>;
<volume>113</volume>:
<fpage>1390</fpage>&#x2013;<lpage>1397</lpage>.
<pub-id pub-id-type="pmid">15146236</pub-id></mixed-citation>
      </ref>
      <ref id="b20">
        <label>20</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Garin</surname><given-names>EH</given-names></name>
<name><surname>Diaz</surname><given-names>LN</given-names></name>
<name><surname>Mu</surname><given-names>W</given-names></name>
<name><surname>Wasserfall</surname><given-names>C</given-names></name>
<name><surname>Araya</surname><given-names>C</given-names></name>
<name><surname>Segal</surname><given-names>M</given-names></name>
<name><surname>Johnson</surname><given-names>RJ</given-names></name>
<article-title>Urinary CD80 excretion increases in idiopathic minimal-change disease.</article-title>
<source>J Am Soc Nephrol</source>.
<year>2009</year>;
<volume>20</volume>:
<fpage>260</fpage>&#x2013;<lpage>266</lpage>.
<pub-id pub-id-type="pmid">19056875</pub-id></mixed-citation>
      </ref>
      <ref id="b21">
        <label>21</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Garin</surname><given-names>EH</given-names></name>
<name><surname>Mu</surname><given-names>W</given-names></name>
<name><surname>Arthur</surname><given-names>JM</given-names></name>
<name><surname>Rivard</surname><given-names>CJ</given-names></name>
<name><surname>Araya</surname><given-names>CE</given-names></name>
<name><surname>Shimada</surname><given-names>M</given-names></name>
<name><surname>Johnson</surname><given-names>RJ</given-names></name>
<article-title>Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.</article-title>
<source>Kidney Int</source>.
<year>2010</year>;
<volume>78</volume>:
<fpage>296</fpage>&#x2013;<lpage>302</lpage>.
<pub-id pub-id-type="pmid">20485332</pub-id></mixed-citation>
      </ref>
      <ref id="b22">
        <label>22</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Reiser</surname><given-names>J</given-names></name>
<name><surname>Mundel</surname><given-names>P</given-names></name>
<article-title>Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome.</article-title>
<source>J Am Soc Nephrol</source>.
<year>2004</year>;
<volume>15</volume>:
<fpage>2246</fpage>&#x2013;<lpage>2248</lpage>.
<pub-id pub-id-type="pmid">15339973</pub-id></mixed-citation>
      </ref>
      <ref id="b23">
        <label>23</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Shimada</surname><given-names>M</given-names></name>
<name><surname>Araya</surname><given-names>C</given-names></name>
<name><surname>Rivard</surname><given-names>C</given-names></name>
<name><surname>Ishimoto</surname><given-names>T</given-names></name>
<name><surname>Johnson</surname><given-names>RJ</given-names></name>
<name><surname>Garin</surname><given-names>EH</given-names></name>
<article-title>Minimal change disease: a &#x201C;two-hit&#x201D; podocyte immune disorder?</article-title>
<source>Pediatr Nephrol</source>.
<year>2011</year>;
<volume>26</volume>:
<fpage>645</fpage>&#x2013;<lpage>649</lpage>.
<pub-id pub-id-type="pmid">21052729</pub-id></mixed-citation>
      </ref>
      <ref id="b24">
        <label>24</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Araya</surname><given-names>C</given-names></name>
<name><surname>Diaz</surname><given-names>L</given-names></name>
<name><surname>Wasserfall</surname><given-names>C</given-names></name>
<name><surname>Atkinson</surname><given-names>M</given-names></name>
<name><surname>Mu</surname><given-names>W</given-names></name>
<name><surname>Johnson</surname><given-names>R</given-names></name>
<name><surname>Garin</surname><given-names>E</given-names></name>
<article-title>T regulatory cell function in idiopathic minimal lesion nephrotic syndrome.</article-title>
<source>Pediatr Nephrol</source>.
<year>2009</year>;
<volume>24</volume>:
<fpage>1691</fpage>&#x2013;<lpage>1698</lpage>.
<pub-id pub-id-type="pmid">19495805</pub-id></mixed-citation>
      </ref>
      <ref id="b25">
        <label>25</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Zorn</surname><given-names>E</given-names></name>
<name><surname>Kim</surname><given-names>HT</given-names></name>
<name><surname>Lee</surname><given-names>SJ</given-names></name>
<name><surname>Floyd</surname><given-names>BH</given-names></name>
<name><surname>Litsa</surname><given-names>D</given-names></name>
<name><surname>Arumugarajah</surname><given-names>S</given-names></name>
<name><surname>Bellucci</surname><given-names>R</given-names></name>
<name><surname>Alyea</surname><given-names>EP</given-names></name>
<name><surname>Antin</surname><given-names>JH</given-names></name>
<name><surname>Soiffer</surname><given-names>RJ</given-names></name>
<name><surname>Ritz</surname><given-names>J</given-names></name>
<article-title>Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.</article-title>
<source>Blood</source>.
<year>2005</year>;
<volume>106</volume>:
<fpage>2903</fpage>&#x2013;<lpage>2911</lpage>.
<pub-id pub-id-type="pmid">15972448</pub-id></mixed-citation>
      </ref>
      <ref id="b26">
        <label>26</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Luo</surname><given-names>XD</given-names></name>
<name><surname>Liu</surname><given-names>QF</given-names></name>
<name><surname>Zhang</surname><given-names>Y</given-names></name>
<name><surname>Sun</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>GB</given-names></name>
<name><surname>Fan</surname><given-names>ZP</given-names></name>
<name><surname>Yi</surname><given-names>ZS</given-names></name>
<name><surname>Ling</surname><given-names>YW</given-names></name>
<name><surname>Wei</surname><given-names>YQ</given-names></name>
<name><surname>Liu</surname><given-names>XL</given-names></name>
<name><surname>Xu</surname><given-names>B</given-names></name>
<article-title>Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis.</article-title>
<source>Blood Cells Mol Dis</source>.
<year>2011</year>;
<volume>46</volume>:
<fpage>182</fpage>&#x2013;<lpage>187</lpage>.
<pub-id pub-id-type="pmid">21212006</pub-id></mixed-citation>
      </ref>
      <ref id="b27">
        <label>27</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Hempel</surname><given-names>L</given-names></name>
<name><surname>Misselwitz</surname><given-names>J</given-names></name>
<name><surname>Fleck</surname><given-names>C</given-names></name>
<name><surname>Kentouche</surname><given-names>K</given-names></name>
<name><surname>Leder</surname><given-names>C</given-names></name>
<name><surname>Appenroth</surname><given-names>D</given-names></name>
<name><surname>Rost</surname><given-names>M</given-names></name>
<name><surname>Zintl</surname><given-names>F</given-names></name>
<article-title>Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.</article-title>
<source>Med Pediatr Oncol</source>.
<year>2003</year>;
<volume>40</volume>:
<fpage>348</fpage>&#x2013;<lpage>354</lpage>.
<pub-id pub-id-type="pmid">12692801</pub-id></mixed-citation>
      </ref>
      <ref id="b28">
        <label>28</label>
        <mixed-citation publication-type="journal" publication-format="undefined">
<name><surname>Naesens</surname><given-names>M</given-names></name>
<name><surname>Kuypers</surname><given-names>DR</given-names></name>
<name><surname>Sarwal</surname><given-names>M</given-names></name>
<article-title>Calcineurin inhibitor nephrotoxicity.</article-title>
<source>Clin J Am Soc Nephrol</source>.
<year>2009</year>;
<volume>4</volume>:
<fpage>481</fpage>&#x2013;<lpage>508</lpage>.
<pub-id pub-id-type="pmid">19218475</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
